Towards Intelligent Healthcare Delivery: A Reinforcement Learning-Enhanced Conversational Agent for Medical Consultation & Patient Engagement

Abstract

This paper presents MediBot, a reinforcement learning-based conversational agent developed for intelligent healthcare consultation and continuous patient engagement. The system integrates advanced natural language understanding methods, including intent recognition through contextual semantic parsing, biomedical entity identification using ontology-guided lexical models, and sentiment analysis via polarity-weighted embeddings. These components operate with a Deep Q-Network policy optimizer that refines dialogue strategies through temporal difference learning and experience replay. MediBot enables coherent, multi-turn medical interactions through adaptive response generation informed by state–action value estimation. Experimental evaluation across intent accuracy, entity extraction precision, sentiment inference, policy convergence, and user engagement demonstrates superior performance over existing healthcare dialogue systems. The results confirm stable policy learning, real-time response capability, and sustained user satisfaction. This work advances computational healthcare by establishing an effective integration of reinforcement learning and domain-specific language understanding for scalable and personalized medical dialogue systems.

Introduction

This research presents an advanced AI-based healthcare conversational system designed to improve clinical decision support and overcome challenges such as physician shortages, high consultation costs, and limited healthcare access. Existing medical chatbots lack strong contextual understanding and multi-turn dialogue management. To address this, the study introduces a novel architecture combining transformer-based NLP with Deep Q-Network (DQN) reinforcement learning for optimized dialogue policy control.

The system includes:

• Intent Classification (rule-based with 12 medical intents)

• Biomedical Named Entity Recognition (DISEASE, CHEMICAL, PROCEDURE)

• Sentiment and urgency detection for emergency handling

• Dialogue State Tracking for multi-turn context management

• Reinforcement Learning-based Dialogue Manager modeled as a Markov Decision Process (MDP) with reward optimization

The reward function balances task completion, user satisfaction, engagement, conversation length, and repetition penalties.

The system was evaluated using intent datasets, medical texts, simulated dialogues, latency tests, and real user sessions, and compared with existing systems such as Ada Health, Babylon AI, Your.MD, and Buoy Health. Performance was measured using NLP metrics (accuracy, precision, recall, F1-score) and reinforcement learning metrics (convergence, reward trends, policy quality, and sample efficiency).

Overall, the study demonstrates a scalable, real-world deployable, multi-modal healthcare chatbot that integrates conversational AI with medical knowledge retrieval and decision support.

Conclusion

This investigation presents MediBot, a reinforcement learning-enhanced conversational agent demonstrating superior performance across multiple evaluation dimensions critical for healthcare delivery. Empirical validation reveals 85.3% intent classification accuracy (surpassing commercial systems by 2.9%), 82.7% entity extraction F1-score (3.2% improvement), sub-300ms response latencies (21.4% faster), and RL policy convergence after 1,847 training episodes with +4.73 stabilized reward (321% improvement over random baseline). The proposed architecture advances healthcare AI through synergistic integration of domain-specific NLP components (intent classification, entity extraction, sentiment analysis) with adaptive dialogue management via Deep Q-Networks. Comparative analysis demonstrates measurable improvements over four commercial alternatives (Ada Health, Babylon AI, Your.MD, Buoy Health), while maintaining computational efficiency suitable for real-time deployment (245.3ms mean latency). These findings illuminate the transformative potential of integrating adaptive decision-making frameworks with domain-specific natural language processing to transcend the limitations of rule-based dialogue management systems that plague existing healthcare chatbots. Not with standing these contributions, several research frontiers warrant further investigation. The integration of large language model architectures particularly domain-adapted biomedical transformers such as BioBERT and PubMedBERT promises enhanced contextual understanding and improved handling of clinical terminology variability. Multi-agent reinforcement learning paradigms could enable specialized sub-dialogue managers for distinct clinical domains (symptomatology, pharmacology, appointment scheduling), potentially improving task-specific performance through modular policy optimization. As global healthcare systems confront unprecedented challenges of accessibility, affordability, and scalability, AI-augmented conversational agents emerge as indispensable infrastructure for democratizing medical knowledge access. This research validates both the technical feasibility and practical viability of deploying reinforcement learning-enhanced dialogue systems in real-world healthcare contexts. The successful integration of adaptive policy optimization with biomedical language understanding establishes a methodological template for next-generation intelligent health assistants capable of delivering personalized, contextually-aware, and clinically grounded medical consultation at scale. Future iterations incorporating electronic health record integration, federated learning for privacy-preserving model refinement, and prospective clinical validation will further bridge the chasm between computational healthcare research and translational medical practice, ultimately advancing toward ubiquitous, equitable, AI-empowered healthcare ecosystems.

References

[1] E. J. Topol, “High-performance medicine: the convergence of human and artificial intelligence,” Nature Medicine, vol. 25, no. 1, pp. 44-56, 2019. [2] AAMC, “The Complexities of Physician Supply and Demand: Projections from 2017 to 2032,” Association of American Medical Colleges, 2019. [3] J. Weizenbaum, “ELIZAA computer program for the study of natural language communication between man and machine,” Commun. ACM, vol. 9, no. 1, pp. 36-45, 1966. [4] A. Pfohl et al., “Symptom assessment with Ada: An evaluation of symptom checker accuracy,” Digital Health, vol. 6, 2020. [5] M. S. Middleton et al., “Artificial intelligence in healthcare: The Babylon Health approach,” BMJ Health & Care Informatics, vol. 26, no. 1, 2019. [6] R. Judson et al., “Your.MD: Personalized health information through AI,” JMIR mHealth uHealth, vol. 6, no. 4, 2018. [7] A. Le et al., “Buoy Health: Intelligent symptom checker powered by clinical data,” NPJ Digital Medicine, vol. 3, no. 1, pp. 1-8, 2020. [8] J. D. Williams et al., “Hybrid code networks: Practical and efficient end-to-end dialog control with supervised and reinforcement learning,” Proc. ACL, pp. 665-677, 2017. [9] J. He et al., “Deep reinforcement learning with a natural language action space,” Proc. ACL, pp. 1621-1630, 2016. [10] B. Dhingra et al., “Towards end-to-end reinforcement learning of dialogue agents for information access,” Proc. ACL, pp. 484-495, 2017. [11] B. Peng et al., “Composite task-completion dialogue policy learning via hierarchical deep reinforcement learning,” Proc. EMNLP, pp. 2231- 2240, 2017. [12] J. Lee et al., “BioBERT: A pre-trained biomedical language representation model for biomedical text mining,” Bioinformatics, vol. 36, no. 4, pp. 1234-1240, 2020. [13] E. Alsentzer et al., “Publicly available clinical BERT embeddings,” Proc. Workshop Clinical Natural Language Processing, pp. 72-78, 2019. [14] Y. Gu et al., “Domain-specific language model pretraining for biomedical natural language processing,” ACM Trans. Computing Healthcare, vol. 3, no. 1, pp. 1-23, 2021. [15] G. Lample et al., “Neural architectures for named entity recognition,” Proc. NAACL-HLT, pp. 260-270, 2016. [16] Q. Wei et al., “A study of deep learning approaches for medication and adverse drug event extraction from clinical text,” J. Am. Med. Inform. Assoc., vol. 27, no. 1, pp. 13-21, 2020. [17] R. S. Sutton and A. G. Barto, Reinforcement Learning: An Introduction, 2nd ed. MIT Press, 2018. [18] V. Mnih et al., “Human-level control through deep reinforcement learning,” Nature, vol. 518, no. 7540, pp. 529-533, 2015. [18] J. Devlin et al., “BERT: Pre-training of deep bidirectional transformers for language understanding,” Proc. NAACL-HLT, pp. 4171-4186, 2019

Copyright

Copyright © 2026 Dr. Sajja Suneel, Janapaneedi Nirmal Sai Swaroop, Akambaram Nagaraju, Kolipaka Prudhvik. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.